537 related articles for article (PubMed ID: 25765348)
21. [Efficacy and tolerability of 5% minoxidil solution (Carexidil®) in male and female androgenetic alopecia: a 6-month open multicentric study].
Piraccini B; Starace M; Alessandrini A; Guarrera M; Fiorucci MC; Lorenzi S
G Ital Dermatol Venereol; 2011 Dec; 146(6 Suppl 1):1-8. PubMed ID: 22189834
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation.
Ghonemy S; Alarawi A; Bessar H
J Dermatolog Treat; 2021 Mar; 32(2):236-241. PubMed ID: 31403367
[TBL] [Abstract][Full Text] [Related]
23. Investigator-blinded, controlled, and randomized comparative study on 1565 nm non-ablative fractional laser versus 5% minoxidil for treatment of androgenetic alopecia.
Qu H; Zhang R; Xin W; Jing H; Wang G; Gao L
J Cosmet Dermatol; 2024 May; 23(5):1638-1644. PubMed ID: 38247260
[TBL] [Abstract][Full Text] [Related]
24. Topical adenosine increases thick hair ratio in Japanese men with androgenetic alopecia.
Watanabe Y; Nagashima T; Hanzawa N; Ishino A; Nakazawa Y; Ogo M; Iwabuchi T; Tajima M
Int J Cosmet Sci; 2015 Dec; 37(6):579-87. PubMed ID: 25925959
[TBL] [Abstract][Full Text] [Related]
25. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
Suchonwanit P; Rojhirunsakool S; Khunkhet S
Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
[TBL] [Abstract][Full Text] [Related]
26. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial.
Panahi Y; Taghizadeh M; Marzony ET; Sahebkar A
Skinmed; 2015; 13(1):15-21. PubMed ID: 25842469
[TBL] [Abstract][Full Text] [Related]
27. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution.
DeVillez RL; Jacobs JP; Szpunar CA; Warner ML
Arch Dermatol; 1994 Mar; 130(3):303-7. PubMed ID: 8129407
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
[TBL] [Abstract][Full Text] [Related]
29. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia.
Blume-Peytavi U; Lönnfors S; Hillmann K; Garcia Bartels N
J Am Acad Dermatol; 2012 May; 66(5):794-800. PubMed ID: 21875758
[TBL] [Abstract][Full Text] [Related]
30. Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study.
Bassiouny EA; El-Samanoudy SI; Abbassi MM; Nada HR; Farid SF
Arch Dermatol Res; 2023 Jul; 315(5):1293-1304. PubMed ID: 36571611
[TBL] [Abstract][Full Text] [Related]
31. Randomized trial of electrodynamic microneedle combined with 5% minoxidil topical solution for the treatment of Chinese male Androgenetic alopecia.
Bao L; Gong L; Guo M; Liu T; Shi A; Zong H; Xu X; Chen H; Gao X; Li Y
J Cosmet Laser Ther; 2020; 22(1):1-7. PubMed ID: 29028377
[No Abstract] [Full Text] [Related]
32. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia.
Arca E; Açikgöz G; Taştan HB; Köse O; Kurumlu Z
Dermatology; 2004; 209(2):117-25. PubMed ID: 15316165
[TBL] [Abstract][Full Text] [Related]
33. The clinical effect of JetpPeel-assisted topical minoxidil in the treatment of androgenetic alopecia: A randomized pilot study.
Gong L; Bao L; Tian T; Li Y
J Cosmet Laser Ther; 2018 Feb; 20(1):58-63. PubMed ID: 29166130
[TBL] [Abstract][Full Text] [Related]
34. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment.
Price VH; Menefee E; Strauss PC
J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):717-21. PubMed ID: 10534633
[TBL] [Abstract][Full Text] [Related]
35. Topical minoxidil therapy for androgenetic alopecia. A 30-month study.
Koperski JA; Orenberg EK; Wilkinson DI
Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study.
Hossein Mostafa D; Samadi A; Niknam S; Nasrollahi SA; Guishard A; Firooz A
J Pharm Pharm Sci; 2021; 24():191-199. PubMed ID: 33909554
[TBL] [Abstract][Full Text] [Related]
37. Treatment of female androgenetic alopecia with minoxidil 2%.
Whiting DA; Jacobson C
Int J Dermatol; 1992 Nov; 31(11):800-4. PubMed ID: 1428436
[TBL] [Abstract][Full Text] [Related]
38. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
[TBL] [Abstract][Full Text] [Related]
39. Topical minoxidil therapy in hereditary androgenetic alopecia.
De Villez RL
Arch Dermatol; 1985 Feb; 121(2):197-202. PubMed ID: 3883902
[TBL] [Abstract][Full Text] [Related]
40. A Comparative Study between the Efficacy and Safety of 5% Minoxidil Solution and 5% Minoxidil Milky Lotion in the Treatment of Male Androgenic Alopecia.
Thuangtong R; Thanomkitti K; Suvanasuthi S
J Med Assoc Thai; 2017 Jan; 100(1):70-7. PubMed ID: 29911772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
